RCKT Rocket Pharmaceuticals Inc
Company Analysis
Latest News
🟢 Rocket Pharmaceuticals is trading 5.8% up in pre-market after FDA alignment on Danon disease trial
Rocket Pharmaceuticals is trading 5.8% up now at $3.61 after announcing FDA alignment on September 15, 2026, supporting continued enrollment and dosing in its...
🔴 Rocket Pharmaceuticals is trading 5.5% down today as biotech falls 2.11%
Rocket Pharmaceuticals is trading 5.5% down at $3.24 now, with the decline appearing driven mainly by broader risk-off conditions. - FDA alignment announced...
Rocket Pharma Secures FDA Alignment on Pivotal Phase 2 Trial for RP-A501
Rocket Pharmaceuticals announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the key design elements for its global pivotal...
🔴 Rocket Pharmaceuticals is trading 5% down today
Rocket Pharmaceuticals is trading 5.03% down at $3.31, extending its decline from $3.48 on September 10, 2026, with no clear new company-specific negative...
🟢 Rocket Pharmaceuticals is trading 9.77% up in pre-market amid Cantor conference updates
Rocket Pharmaceuticals is trading 9.77% up at $3.82 after opening the September 11, 2026 pre-market session higher following a broader risk-on tone. - The...
🔴 Rocket Pharmaceuticals is trading 5.23% down today after hotter-than-expected producer-inflation data
Rocket Pharmaceuticals is trading 5.23% down at $3.44 after broader market selling following hotter-than-expected producer-inflation data. - The S&P 500,...
🟢 Rocket Pharmaceuticals is trading 7.61% up in pre-market with no clear catalyst identified
Rocket Pharmaceuticals is trading 7.61% up in pre-market at $3.91 after rising from the September 09, 2026 close of $3.63, with no fresh company announcement...
🟢 Rocket Pharmaceuticals is trading 5.76% up today — no clear catalyst identified
Rocket Pharmaceuticals is trading now at $3.94, up 5.76%, with no clear company-specific catalyst identified. - Live-market data is for September 2, 2026; no...
🔴 Rocket Pharmaceuticals is trading 5.31% down today with no fresh company-specific catalyst identified
Rocket Pharmaceuticals is trading 5.31% down at $3.65, with no new company-specific announcement identified for August 31, 2026. - Latest official releases...
🟢 Rocket Pharmaceuticals is trading 6.05% up today; no company-specific catalyst identified
Rocket Pharmaceuticals is trading at $3.84, up +6.05%, with no new company-specific announcement identified for August 28, 2026. - Latest releases covered...
🔴 Rocket Pharmaceuticals is trading 5.16% down today with no fresh company-specific catalyst identified
Rocket Pharmaceuticals is trading 5.16% down at $3.58, with no new company-specific announcement identified for August 26, 2026. - Latest listed releases...
🟢 Rocket Pharmaceuticals is trading 5% up today as biotech sector gains 2.06%
Rocket Pharmaceuticals is trading 5% up at $3.71, with the move appearing primarily sector-driven as the biotech sector gains 2.06% during the August 25, 2026,...
🔴 Rocket Pharmaceuticals is trading 5.75% down today as investors take profits after Moderna-driven enthusiasm
Rocket Pharmaceuticals is trading 5.75% down at $3.44 as investors take profits following Moderna-driven enthusiasm. - No fresh company-specific announcement...
🟢 Rocket Pharmaceuticals is trading 6.3% up today after positive mRNA cancer-vaccine trial results
Rocket Pharmaceuticals is trading 6.29% up at $3.58 after broad biotechnology sentiment strengthened on positive mRNA cancer-vaccine trial results. - No fresh...
🔴 Rocket Pharmaceuticals is trading 7.5% down in pre-market with no clear company-specific catalyst
Rocket Pharmaceuticals is trading 7.51% down at $3.21 after no clear company-specific catalyst emerged overnight. • The latest company release was...
Rocket Pharma Clears a Safety Hurdle for Its Heart Disease Gene Therapy — But Can Three Patients Justify a 10% Rally?
Shares of Rocket Pharmaceuticals surged 10.1% to $3.42 after the company reported that the first three patients treated under a revised dosing plan for its...
🔴 Rocket Pharmaceuticals is trading 7% down today with no clear catalyst
Rocket Pharmaceuticals is trading 7% down at $3.25 following the market close, despite a lack of fundamental news or corporate updates to explain the move. •...
🔴 Rocket Pharmaceuticals is trading 7.0% down today in after-hours trading with no clear catalyst
Rocket Pharmaceuticals is trading at $3.25 (-7.02%) in after-hours trading following a regular session close of $3.50, with no verified company-specific news...
Rocket Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Consensus estimates for Rocket Pharmaceuticals place Q2 2026 revenue at $0.22 million and EPS at $0.28, with the stock currently trading near $3.41 against an...
🔴 Rocket Pharmaceuticals is trading 5.9% down today in a pullback after its Danon trial rally
Rocket Pharmaceuticals is trading 5.9% down at $3.21 as the stock pulls back from yesterday's significant gains. • The stock jumped over 10% on August 3,...